Prognostic value of cardio-hepatic-skeletal muscle syndrome in patients with heart failure.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 02 2021
Historique:
received: 26 10 2020
accepted: 16 12 2020
entrez: 13 2 2021
pubmed: 14 2 2021
medline: 15 12 2021
Statut: epublish

Résumé

Although heart failure (HF) and liver dysfunction often coexist because of complex cardiohepatic interactions, the association between liver dysfunction and physical dysfunction, and between coexistence of both and prognosis in HF patients remains unclear. We reviewed 895 patients with HF (mean age, 69.4 ± 14.2 years) who underwent liver function test using model for end-stage liver disease excluding international normalized ratio (MELD-XI) score and physical function test (grip strength, leg strength, gait speed, and 6-min walking distance [6MWD]). In the multiple regression analysis, MELD-XI score was independently associated with lower grip strength, leg strength, gait speed, and 6MWD (all P < 0.001). One hundred thirty deaths occurred over a median follow-up period of 1.67 years (interquartile range: 0.62-3.04). For all-cause mortality, patients with high MELD-XI scores and reduced physical functions were found to have a significantly higher mortality risk even after adjusting for several covariates (grip strength, hazard ratio [HR]: 3.80, P < 0.001; leg strength, HR: 4.65, P < 0.001; gait speed, HR: 2.49, P = 0.001, and 6MWD, HR: 5.48, P < 0.001). Liver dysfunction was correlated with reduced physical function. Moreover, the coexistence of lower physical function and liver dysfunction considerably affected prognosis in patients with HF.

Identifiants

pubmed: 33580115
doi: 10.1038/s41598-020-80641-2
pii: 10.1038/s41598-020-80641-2
pmc: PMC7880995
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3715

Références

Redox Biol. 2019 Jan;20:296-306
pubmed: 30388684
Cochrane Database Syst Rev. 2017 May 18;5:CD001939
pubmed: 28518283
J Clin Exp Hepatol. 2017 Dec;7(4):340-357
pubmed: 29234200
J Cell Physiol. 2017 Dec;232(12):3775-3785
pubmed: 28181692
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Circulation. 1993 Jul;88(1):107-15
pubmed: 8319323
J Nutr Health Aging. 2019;23(10):949-957
pubmed: 31781724
J Hepatol. 2018 Apr;68(4):707-714
pubmed: 29221886
J Am Coll Cardiol. 2019 May 7;73(17):2209-2225
pubmed: 31047010
Circ J. 2016 Sep 23;80(10):2073-80
pubmed: 27581346
Am J Med Sci. 2017 Mar;353(3):265-274
pubmed: 28262214
Eur Heart J. 2013 Mar;34(10):742-9
pubmed: 23091203
JACC Heart Fail. 2019 Feb;7(2):87-97
pubmed: 30553904
J Am Geriatr Soc. 2019 Dec;67(12):2568-2573
pubmed: 31418823
Front Physiol. 2018 Jun 29;9:763
pubmed: 30013482
J Am Coll Cardiol. 2013 Jun 4;61(22):2253-2261
pubmed: 23563127
Liver Transpl. 2007 Jan;13(1):30-7
pubmed: 17154400
Int J Cardiol. 2017 Jul 1;238:5-11
pubmed: 28427849
Nutr Cancer. 2018 Feb-Mar;70(2):176-183
pubmed: 29351494
J Cell Physiol. 2013 Jul;228(7):1452-63
pubmed: 23255067
N Engl J Med. 2013 Dec 26;369(26):2525-34
pubmed: 24369077
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Sci Rep. 2020 Sep 30;10(1):16093
pubmed: 32999391
Eur J Prev Cardiol. 2018 Sep;25(14):1463-1481
pubmed: 29442529
Aliment Pharmacol Ther. 2016 Apr;43(7):765-77
pubmed: 26847265
J Heart Lung Transplant. 2012 Jun;31(6):591-600
pubmed: 22458996
Cold Spring Harb Perspect Med. 2017 Nov 1;7(11):
pubmed: 28389517
J Am Coll Cardiol. 2013 Jun 18;61(24):2397-2405
pubmed: 23603231
Respir Res. 2019 Dec 9;20(1):279
pubmed: 31818285
J Exp Biol. 2011 Jan 15;214(Pt 2):337-46
pubmed: 21177953
Aliment Pharmacol Ther. 2020 Jan;51(1):64-77
pubmed: 31701570
J Gastroenterol. 2019 Oct;54(10):845-859
pubmed: 31392488
Tohoku J Exp Med. 2016;240(3):221-226
pubmed: 27867155

Auteurs

Takumi Noda (T)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Kentaro Kamiya (K)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan. k-kamiya@kitasato-u.ac.jp.
Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0375, Japan. k-kamiya@kitasato-u.ac.jp.

Nobuaki Hamazaki (N)

Department of Rehabilitation, Kitasato University Hospital, Sagamihara, Japan.

Kohei Nozaki (K)

Department of Rehabilitation, Kitasato University Hospital, Sagamihara, Japan.

Takafumi Ichikawa (T)

Department of Rehabilitation, Kitasato University Hospital, Sagamihara, Japan.

Takeshi Nakamura (T)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Masashi Yamashita (M)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Shota Uchida (S)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Emi Maekawa (E)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Jennifer L Reed (JL)

Exercise Physiology and Cardiovascular Health Lab, Division of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Canada.
Faculty of Medicine, University of Ottawa, Ottawa, Canada.
School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada.

Minako Yamaoka-Tojo (M)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.
Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0375, Japan.

Atsuhiko Matsunaga (A)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.
Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0375, Japan.

Junya Ako (J)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH